pRb2/p130 and VEGF expression in endometrial carcinoma in relation to angiogenesis and histopathologic tumor grade

Cancer Biology and Therapy

Volumn 5, Issue 1, 2006, Pages 84-88

  Sanseverino, Francesca ^a,b   Santopietro, Rosa ^a   Torricelli, Michela ^a   D'Andrilli, Giuseppina ^b   Russo, Giuseppe ^a,b   Cevenini, Gabriele ^a   Bovicelli, Alessandro ^b,c   Leoncini, Lorenzo ^a   Scambia, Giovanni ^d   Petraglia, Felice ^a   Claudio, Pier Paolo ^b   Giordano, Antonio ^a,b,e  

^a UNIVERSITY OF SIENA   (Italy)

^b Temple University   (United States)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e TEMPLE UNIVERSITY   (United States)

Author keywords

Angiogenesis; Endometrial cancer; Grading; Staging; Tumor suppressor gene

Indexed keywords

PROTEIN P130; RETINOBLASTOMA PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PROTEIN EXPRESSION; TUMOR NECROSIS; TUMOR VASCULARIZATION;

EID: 32544438320     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.5.1.2345     Document Type: Article

References (27)

1. Minelli L, Stracci F, Prandini S, Moffa IF, La Rosa F. Gynaecological cancers in Umbria (Italy): Trends of incidence, mortality and survival, 1978-1998. Eur J Obstet Gynecol Reprod Biol 2004; 115:59-65.
2. Paltoo DN, Chu KC. Patterns in cancer incidence among American Indians/Alaska Natives, United States, 1992-1999. Public Health Rep 2004; 119:443-451.
3. Boyle P, Leon ME, Maisonneuve P, Autier P. Cancer control in women. Int J Gynaecol Obstet 2003; 83:179-202, (Update 2003).
4. Ayhan A, Celik H, Coskun F, Baykal C, Salman MC, Aksan G. Restaging in gynaecological cancers. Eur J Gynaecol Oncol 2005; 26:25-30.
5. In: Creasman WT, ed. Announcements: FIGO stages-1988 revision. Gynecol Oncol 1989; 35:125-127.
6. Lax SF, Kurman RJ, Pizer ES, Wu L, Ronnett BM. A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis. Am J Surg Pathol 2000; 24:1201-1208.
7. In: Kurman RJ, ed. Blaustein's pathology of the female genital tract. 4th ed. New York: Springer-Verlag, 1994:439-86.
8. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002; 29:15-8.
9. Sivridis E. Angiogenesis and endometrial cancer. Anticancer Res 2001; 21:4383-8.
10. Obermair A, Tempfer C, Wasicky R, Kaider A, Hefler L, Kainz C. Prognostic significance of tumor angiogenesis in endometrial cancer. Obstet Gynecol 1999; 93:367-371.
11. Rak J, Yu JL. Oncogenes and tumor angiogenesis: The question of vascular "supply" and vascular "demand". Semin Cancer Biol 2004; 14:93-104.
12. Claudio PP, Stiegler P, Howard CM, Bellan C, Minimo C, Tosi GM, Rak J, Kovatich A, De Fazio P, Micheli P, Caputi M, Leoncini L, Kerbel R, Giordano GG, Giordano A. RB2/p130 gene-enhanced expression downregulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo. Cancer Res 2001; 61:462-8.
13. Ewen ME, Xing YG, Lawrence JB, Livingston DM. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 1991; 66:1155-64.
14. Mayol X, Grana X, Baldi A, Sang N, Hu Q, Giordano A. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene 1993; 8:2561-6.
15. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence. Science 1987; 235:1394-9.
16. Helt AM, Galloway DA. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 2003; 24:159-69.
17. Susini T, Baldi F, Howard CM, Baldi A, Taddei G, Massi D, Rapi S, Savino L, Massi G, Giordano A. Expression of the retinoblastoma-related gene Rb2/p130 correlates with clinical outcome in endometrial cancer. J Clin Oncol 1998; 16:1085-93.
18. Claudio PP, Russo G, Kumar CA, Minimo C, Farina A, Tutton S, Nuzzo G, Giuliante F, Angeloni G, Maria V, Vecchio FM, Campli CD, Giordano A. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: Their clinical significance. Clin Cancer Res 2004; 10:3509-17.
19. Shepherd JH. Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol 1989; 96:889-92.
20. Horn LC, Schnurrbusch U, Bilek K, Hentschel B, Einenkel J. Risk of progression in complex and atypical endometrial hyperplasia: Clinicopathologic analysis in cases with and without progestogen treatment. Int J Gynecol Cancer 2004; 14:348-53.
21. Creasman WT. One score + 11 = 2000. Gynecol Oncol 1989; 34:255-7.
22. Hachisuga T, Kawarabayashi T, Iwasaka T, Sugimori H, Kamura T, Tsuneyoshi M. The prognostic value of semiquantitative nuclear grading in endometrial carcinomas. Gynecol Oncol 1997; 65:115-20.
23. Mittal KR, Schwartz PE, Barwick KW. Architectural (FIGO) grading, nuclear grading, and other prognostic indicators in stage I endometrial adenocarcinoma with identification of high-risk and low-risk groups. Cancer 1988; 61:538-45.
24. Christopherson WM, Connelly PJ, Alberhasky RC. Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and Stage I disease. Cancer 1983; 51:1705-9.
25. Russo G, Claudio PP, Fu Y, Stiegler P, Yu Z, Macaluso M, Giordano A. pRB2/p130 target genes in nonsmall lung cancer cells identified by microarray analysis. Oncogene 2003; 22:6959-69.
26. Poon RT, Fan ST, Wong J. Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 2001; 19:1207-25.
27. Susini T, Massi D, Paglierani M, Masciullo V, Scambia G, Giordano A, Amunni G, Massi G, Taddei GL. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma. Hum Pathol 2001; 32:360-7.